Show results for
Refine by
Nervous And Circulatory System Equipment Supplied In Spain
8 equipment items found
by:Gain Therapeutics, Inc. based inBethesda, MARYLAND (USA)
Gaucher disease is the most common lysosomal storage disease and is caused by mutations in GBA, the gene that encodes the beta-glucocerebrosidase (GCase) enzyme. These mutations result in the misfolding and subsequent dysfunction of GCase, which leads to the toxic buildup of fat in a variety of organs and tissues such as the liver, spleen, bones and central nervous system (CNS). While there is ...
by:Gain Therapeutics, Inc. based inBethesda, MARYLAND (USA)
Krabbe disease is a severe neurodegenerative disorder caused by mutations in GALC, the gene that encodes the galactosylceramidase (GALC) enzyme. These mutations cause GALC misfolding and dysfunction, which leads to the toxic buildup up fats in the central nervous system (CNS) and ultimately leads to the demyelination and death of neurons. There is no cure for this disease and most patients will ...
Manufactured by:IMG Pharma Biotech S.L. based inDerio - Bizkaia, SPAIN
Parkinsonized Macaca Fascicularis Primate Cell Membrane Microarray, Pack of 1 slide containing cell membranes extracted from several tissues/organs, depending on the ...
Manufactured by:Suvoda based inConshohocken, PENNSYLVANIA (USA)
Our advanced patient randomization and trial supply management system. Your clinical trial command and control ...
Manufactured by:Orliman S.L.U. based inLa Pobla de Vallbona, SPAIN
Indications: Injuries to the central nervous system (cerebral palsy, trauma, etc.). Spinal cord injuries affecting the upper limbs (poliomyelitis, amyotrophic lateral sclerosis, etc.). Injuries to the brachial plexus. Traumatic injuries affecting the upper ...
Manufactured by:Pellenc ST based inPertuis Cedex 4, FRANCE
Central Nervous System: the answer to our clients' need for machine upgradability. Our clients’ main challenge is securing their investment against obsolescence in the context of rapidly changing regulations impacting quality and sorting requirements. ...
by:Gain Therapeutics, Inc. based inBethesda, MARYLAND (USA)
Mucopolysaccharidosis type 1 (MPS 1) is a rare lysosomal storage disease that is caused by mutations in IDUA, the gene that encodes the alpha-L-iduronidase (IDUA) enzyme. These mutations cause the misfolding and dysfunction of IDUA, which leads to the toxic buildup of large sugars in the bone, cartilage, cornea, heart and central nervous system (CNS). There is currently no cure for these ...
Manufactured by:Zoetis Services LLC based inParsippany, NEW JERSEY (USA)
Every day around the globe Alfaxan Multidose Intravenous Injectable Anesthetic is used in thousands of anesthetic procedures. Its effectiveness, wide safety profile and versatility is raising the bar for injectable agents used in induction and total injectable anesthetic procedures. Drug use and dependence: Alfaxalone is a class IV controlled substance. Biochemical and research data suggest that ...